| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.18B | 1.25B | 1.33B | 918.93M | 524.53M | 499.63M |
| Gross Profit | 732.10M | 775.72M | 825.88M | 574.89M | 312.25M | 303.12M |
| EBITDA | 489.55M | 295.55M | 741.80M | 666.71M | 326.30M | 323.19M |
| Net Income | -367.31M | -654.49M | -278.26M | 40.90M | 66.66M | 72.19M |
Balance Sheet | ||||||
| Total Assets | 9.86B | 10.65B | 12.64B | 13.85B | 4.26B | 3.81B |
| Cash, Cash Equivalents and Short-Term Investments | 43.34M | 68.92M | 25.70M | 60.96M | 13.18M | 15.30M |
| Total Debt | 4.72B | 4.96B | 5.30B | 5.70B | 1.92B | 1.71B |
| Total Liabilities | 5.11B | 5.35B | 5.71B | 6.17B | 2.07B | 1.86B |
| Stockholders Equity | 4.68B | 5.23B | 6.82B | 7.57B | 2.19B | 1.95B |
Cash Flow | ||||||
| Free Cash Flow | 219.16M | 252.64M | 268.79M | 109.20M | 131.94M | 376.13M |
| Operating Cash Flow | 462.77M | 501.62M | 499.82M | 272.75M | 232.63M | 470.09M |
| Investing Cash Flow | 603.00M | 900.92M | 349.14M | 1.63B | -562.47M | -555.17M |
| Financing Cash Flow | -1.05B | -1.36B | -884.22M | -1.86B | 327.72M | 99.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $8.27B | 27.59 | 8.13% | 3.56% | 59.25% | 88.37% | |
77 Outperform | $3.82B | 25.25 | 10.87% | 4.73% | 8.04% | 9.20% | |
74 Outperform | $4.70B | 25.91 | 6.29% | 6.47% | 8.12% | 75.95% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | $1.73B | 49.72 | 3.49% | 6.70% | 11.89% | -68.41% | |
56 Neutral | $5.93B | -15.82 | -7.26% | 6.56% | -6.59% | 33.35% | |
48 Neutral | $3.04B | -4.33 | -14.02% | 6.57% | 45.56% | 73.44% |
On January 7, 2026, Healthcare Realty Trust announced that investment banking veteran Daniel Gabbay will become Executive Vice President and Chief Financial Officer, effective January 12, 2026, based at the company’s Nashville headquarters. Gabbay, who has nearly two decades of real estate investment banking experience and deep specialization in the healthcare REIT sector, will receive a compensation package that includes base salary, cash and equity incentives, a make-whole restricted stock grant, and relocation benefits, with his employment agreement outlining severance protections and full vesting of equity in the event of certain terminations, including following a change in control. The company simultaneously disclosed that current CFO Austen Helfrich, who has served as CFO since October 2024 and joined Healthcare Realty in 2019, will depart on January 12, 2026 to pursue new opportunities; his exit is not due to any disagreement with management or auditors and will be treated as a termination other than for cause under his contract, prompting an expected charge of about $5 million in the quarter ending March 31, 2026. Healthcare Realty emphasized continuity by affirming there is no change to its previously raised 2025 Normalized FFO guidance, signaling that the CFO transition is not expected to alter its near-term financial outlook or its positioning as a leading outpatient medical REIT.
The most recent analyst rating on (HR) stock is a Hold with a $17.50 price target. To see the full list of analyst forecasts on Healthcare Realty Trust stock, see the HR Stock Forecast page.
On December 17, 2025, Healthcare Realty Trust announced it entered equity distribution agreements and master forward confirmations with several financial firms for an equity offering program worth up to $1 billion. The move allows the company to issue Class A common stock and potentially engage in forward sale agreements to generate proceeds for general corporate purposes, including healthcare facility projects and debt repayment, reflecting a strategic step to secure capital for growth and strengthen its market positioning.
The most recent analyst rating on (HR) stock is a Hold with a $17.50 price target. To see the full list of analyst forecasts on Healthcare Realty Trust stock, see the HR Stock Forecast page.
Healthcare Realty Trust reported a GAAP net loss of $0.17 per share for the third quarter of 2025, with Normalized FFO of $0.41 per share and a same-store cash NOI growth of 5.4%, driven by increased occupancy and tenant retention. The company executed leases totaling 1.6 million square feet and completed asset sales worth $404 million, with additional sales under contract, reflecting strategic market exits and property monetizations. The company also advanced its development and redevelopment projects, enhancing its portfolio in key markets. The board approved a dividend of $0.24 per share, and the company increased its guidance for Normalized FFO per share and same-store cash NOI growth for 2025.
The most recent analyst rating on (HR) stock is a Hold with a $18.00 price target. To see the full list of analyst forecasts on Healthcare Realty Trust stock, see the HR Stock Forecast page.